Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients

BACKGROUND: This study was initiated to investigate the difference in HER2 status between tumor tissue and circulating tumor cells (CTCs), as well as the predictive value of CTC HER2 status for predicting the outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer (MBC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Autores principales: Zhang, Shaohua, Li, Lei, Wang, Tao, Bian, Li, Hu, Haixu, Xu, Chunhong, Liu, Bing, Liu, Yi, Cristofanilli, Massimo, Jiang, Zefei
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4960713/
https://ncbi.nlm.nih.gov/pubmed/27456503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2578-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares